Cochrane · systematic review · CD004739
Hyperbaric oxygen for idiopathic sudden sensorineural hearing loss and tinnitus
Bennett, MH, Kertesz, T, Perleth, M, et al. · Cochrane Database of Systematic Reviews · 2012 · Cochrane Library
ENTAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
3
current version
GRADE rated
3
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 3 · 100%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Hyperbaric oxygen therapy for idiopathic sudden sensorineural hearing loss or tinnitus
Population: patients with idiopathic sudden sensorineural hearing loss or tinnitus
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Mean improvement in pure‐tone average hearing threshold across all frequencies Decibels Scale from: 0 to 120 | no estimate extracted | 4 studies · 169 participants | Moderate |
More than 50% improvement in pure‐tone average threshold Risk ratio | RR 1.53 [0.85, 2.78] | 2 studies · 114 participants | Moderate |
More than 25% improvement in pure‐tone average threshold Risk ratio | RR 1.39 [1.05, 1.84] | 2 studies · 114 participants | Moderate |